Intermediate versus short-course hormone therapy and mortality in men with high-risk prostate cancer treated with radiation therapy

被引:0
|
作者
Nanda, Akash
Chen, Ming-Hui
Moran, Brian Joseph
Braccioforte, Michelle H.
D'Amico, Anthony Victor
机构
[1] MD Anderson Canc Ctr Orlando, Orlando, FL USA
[2] Univ Connecticut, Storrs, CT USA
[3] Prostate Canc Fdn Chicago, Westmont, IL USA
[4] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
D O I
10.1200/jco.2013.31.6_suppl.83
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
83
引用
收藏
页数:1
相关论文
共 50 条
  • [21] A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer
    Hamid, Muhammad
    Heilbrun, Lance K.
    Maier, Jordan
    Devisetty, Kiran
    Connolly, Irene
    Kaufman, Isaac
    Dobson, Kimberlee
    Herroon, Mackenzie K.
    Smith, Daryn
    Sampson, Sandra
    Podgorski, Izabela
    Heath, Elisabeth I.
    ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (04)
  • [22] Management of high-risk prostate cancer: Radiation therapy and hormonal therapy
    Nomiya, Takuma
    Tsuji, Hiroshi
    Toyama, Shingo
    Maruyama, Katsuya
    Nemoto, Kenji
    Tsujii, Hirohiko
    Kamada, Tadashi
    CANCER TREATMENT REVIEWS, 2013, 39 (08) : 872 - 878
  • [23] Focal therapy in intermediate- and high-risk prostate cancer
    Nicolai A. Huebner
    Stephan Korn
    Pawel Rajwa
    Shahrokh F. Shariat
    memo - Magazine of European Medical Oncology, 2023, 16 : 247 - 250
  • [24] Focal therapy in intermediate- and high-risk prostate cancer
    Huebner, Nicolai A.
    Korn, Stephan
    Rajwa, Pawel
    Shariat, Shahrokh F.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (04) : 247 - 250
  • [25] Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
    Cagney, Daniel N.
    Dunne, Mary
    O'Shea, Carmel
    Finn, Marie
    Noone, Emma
    Sheehan, Martina
    McDonagh, Lesley
    O'Sullivan, Lydia
    Thirion, Pierre
    Armstrong, John
    BMC UROLOGY, 2017, 17
  • [26] Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
    Daniel N. Cagney
    Mary Dunne
    Carmel O’Shea
    Marie Finn
    Emma Noone
    Martina Sheehan
    Lesley McDonagh
    Lydia O’Sullivan
    Pierre Thirion
    John Armstrong
    BMC Urology, 17
  • [27] Diabetes and the risk of death in men with favorable or high-risk prostate cancer following radiation therapy
    D'Amico, A. V.
    Braccioforte, M. H.
    Moran, B. J.
    Chen, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] PREDICTORS OF PROSTATE CANCER SPECIFIC MORTALITY IN ELDERLY MEN WITH INTERMEDIATE-RISK PROSTATE CANCER TREATED WITH BRACHYTHERAPY WITH OR WITHOUT EXTERNAL BEAM RADIATION THERAPY
    Nanda, Akash
    Chen, Ming-Hui
    Moran, Brian J.
    Braccioforte, Michelle H.
    Dosoretz, Daniel
    Salenius, Sharon
    Katin, Michael
    Ross, Rudi
    D'Amico, Anthony V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (01): : 147 - 152
  • [29] Preoperative short-course radiation therapy with PROtons compared to photons in high-risk RECTal cancer (PRORECT): Initial dosimetric experience
    Pedone, Cristiana
    Sorcini, Bruno
    Staff, Caroline
    Farlin, Johanna
    Fokstuen, Tone
    Frodin, Jan-Erik
    Nilsson, Per J.
    Martling, Anna
    Valdman, Alexander
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 39
  • [30] Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk
    Braunstein, Lior Z.
    Chen, Ming-Hui
    Dosoretz, Daniel E.
    Salenius, Sharon A.
    Katin, Michael J.
    Nanda, Akash
    D'Amico, Anthony V.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (06) : 555 - 561